Broadfin Capital’s Cidara Therapeutics CDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-18,791
| Closed | -$1.5M | – | 43 |
|
|
2018
Q1 | $1.5M | Sell |
18,791
-24,079
| -56% | -$1.93M | 0.23% | 45 |
|
|
2017
Q4 | $5.83M | Buy |
42,870
+1,850
| +5% | +$252K | 0.95% | 27 |
|
|
2017
Q3 | $6.65M | Buy |
41,020
+206
| +0.5% | +$33.4K | 0.98% | 24 |
|
|
2017
Q2 | $6.12M | Buy |
40,814
+12,670
| +45% | +$1.9M | 0.74% | 30 |
|
|
2017
Q1 | $4.39M | Hold |
28,144
| – | – | 0.53% | 33 |
|
|
2016
Q4 | $5.85M | Buy |
28,144
+19,800
| +237% | +$4.12M | 0.65% | 38 |
|
|
2016
Q3 | $1.91M | Hold |
8,344
| – | – | 0.17% | 62 |
|
|
2016
Q2 | $1.72M | Hold |
8,344
| – | – | 0.17% | 58 |
|
|
2016
Q1 | $2.12M | Hold |
8,344
| – | – | 0.2% | 59 |
|
|
2015
Q4 | $2.86M | Hold |
8,344
| – | – | 0.18% | 71 |
|
|
2015
Q3 | $2.12M | Buy |
8,344
+844
| +11% | +$215K | 0.12% | 76 |
|
|
2015
Q2 | $2.1M | Buy |
+7,500
| New | +$2.1M | 0.11% | 84 |
|